"Immunoglobulin G" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
| Descriptor ID |
D007074
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393 D12.776.124.790.651.114.619.393 D12.776.377.715.548.114.619.393
|
| Concept/Terms |
IgG(T)- IgG(T)
- Immunoglobulin GT
- GT, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin G".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin G".
This graph shows the total number of publications written about "Immunoglobulin G" by people in this website by year, and whether "Immunoglobulin G" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 8 | 11 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 6 | 7 |
| 1999 | 6 | 9 | 15 |
| 2000 | 3 | 10 | 13 |
| 2001 | 3 | 8 | 11 |
| 2002 | 5 | 8 | 13 |
| 2003 | 2 | 9 | 11 |
| 2004 | 5 | 9 | 14 |
| 2005 | 4 | 11 | 15 |
| 2006 | 5 | 5 | 10 |
| 2007 | 9 | 7 | 16 |
| 2008 | 5 | 15 | 20 |
| 2009 | 2 | 10 | 12 |
| 2010 | 3 | 7 | 10 |
| 2011 | 3 | 9 | 12 |
| 2012 | 6 | 16 | 22 |
| 2013 | 5 | 12 | 17 |
| 2014 | 8 | 17 | 25 |
| 2015 | 7 | 17 | 24 |
| 2016 | 5 | 8 | 13 |
| 2017 | 3 | 15 | 18 |
| 2018 | 3 | 11 | 14 |
| 2019 | 2 | 15 | 17 |
| 2020 | 4 | 13 | 17 |
| 2021 | 3 | 13 | 16 |
| 2022 | 3 | 28 | 31 |
| 2023 | 0 | 21 | 21 |
| 2024 | 5 | 8 | 13 |
| 2025 | 3 | 11 | 14 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulin G" by people in Profiles.
-
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol. 2026 May 01; 83(5):461-470.
-
Whose Line Is it Anyway? Defining Seropositivity Cutoffs for Infectious Disease Surveillance. J Infect Dis. 2026 Apr 29; 233(4):e862-e871.
-
Helminth coinfections mitigate clinical, parasitological, and immune outcomes in Mozambican children with malaria. BMC Med. 2026 Mar 31; 24(1).
-
A metabolic alarmin from keratinocytes potentiates systemic humoral immunity. Nature. 2026 04; 652(8108):209-219.
-
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost. Sci Transl Med. 2026 Feb 25; 18(838):eaeb9837.
-
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial. Infection. 2026 Feb; 54(1):473-485.
-
Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants. Nat Commun. 2025 Oct 16; 16(1):9182.
-
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. J Infect Dis. 2025 Oct 15; 232(4):971-981.
-
Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare System. Clin Gastroenterol Hepatol. 2026 May; 24(5):1289-1297.
-
Expanding cholera serosurveillance to vaccinated populations. mBio. 2025 Nov 12; 16(11):e0189825.